Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice
Year: 2002
Type: article
Source: Brain Research
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Eli Lilly and Company, AstraZeneca
OpenAlex ID: W2071248867
